Lund University

Over the next three years, Immunovia and its partners will use the firm's Immray PanCan-d assay to screen 6,000 diabetes patients for pancreatic cancer.

Evaluation Bias

New study finds bias against female lecturers among student course evaluations, the Economist reports.

The company said that it can distinguish patients suffering from lupus from those with other autoimmune diseases using its antibody array platform.

The European Commission recently awarded the researchers €1.5 million to probe the mechanics of heart failure using proteomic, genomic, and epidemiological approaches.

In the study, the partners will perform exome sequencing and whole-genome array genotyping on more than 9,000 individuals with diabetes or with diabetic relatives.

Initially studying pancreatic tissue, the team also linked their findings to methylation patterns in blood, suggesting the possibility of developing a non-invasive test.

The Swedish firm, a spinout of Lund University, will evaluate the array-based blood tests to confirm, rule out, and monitor the autoimmune disease.

Low-pass sequencing and digital PCR analysis of cell-free circulating tumor DNA could detect metastatic disease in primary breast cancer patients months before clinical diagnosis.

Researchers used SNP arrays to find that separate samples from the same tumors and from primary and metastatic tumors in children were highly genomically diverse.

NEW YORK (GenomeWeb) — Researchers from Lund University in Sweden have reported the first positive results from a study in which they treated a genetic subset of diabetes patients with a currently available drug that targets the suspected genetic architecture of their disease.

Pages

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more